GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 817 filers reported holding GLAXOSMITHKLINE PLC in Q3 2020. The put-call ratio across all filers is 0.91 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $11,287,000 | +30.5% | 259,320 | +30.6% | 0.02% | +57.1% |
| Q1 2022 | $8,648,000 | +53.4% | 198,494 | +55.3% | 0.01% | +55.6% |
| Q4 2021 | $5,638,000 | +26.4% | 127,847 | +9.5% | 0.01% | +12.5% |
| Q3 2021 | $4,461,000 | +6.5% | 116,764 | +11.1% | 0.01% | 0.0% |
| Q2 2021 | $4,187,000 | +16.1% | 105,136 | +4.1% | 0.01% | +14.3% |
| Q1 2021 | $3,605,000 | -8.7% | 100,977 | -5.9% | 0.01% | -22.2% |
| Q4 2020 | $3,950,000 | -17.2% | 107,337 | -15.3% | 0.01% | -25.0% |
| Q3 2020 | $4,768,000 | -9.6% | 126,690 | -2.0% | 0.01% | -14.3% |
| Q2 2020 | $5,275,000 | +3.9% | 129,323 | -3.5% | 0.01% | -12.5% |
| Q1 2020 | $5,079,000 | -24.0% | 134,054 | -5.8% | 0.02% | -5.9% |
| Q4 2019 | $6,686,000 | +21.7% | 142,281 | +10.5% | 0.02% | +13.3% |
| Q3 2019 | $5,493,000 | +7.7% | 128,753 | +1.0% | 0.02% | +7.1% |
| Q2 2019 | $5,099,000 | -8.3% | 127,424 | -4.2% | 0.01% | -12.5% |
| Q1 2019 | $5,562,000 | -15.5% | 133,077 | -22.8% | 0.02% | -23.8% |
| Q4 2018 | $6,586,000 | -40.0% | 172,368 | -36.9% | 0.02% | -34.4% |
| Q3 2018 | $10,975,000 | +58.6% | 273,220 | +59.1% | 0.03% | +52.4% |
| Q2 2018 | $6,922,000 | -3.7% | 171,738 | -6.6% | 0.02% | -4.5% |
| Q1 2018 | $7,186,000 | -3.8% | 183,900 | -12.6% | 0.02% | -4.3% |
| Q4 2017 | $7,467,000 | -46.0% | 210,492 | -38.2% | 0.02% | -47.7% |
| Q3 2017 | $13,827,000 | -23.8% | 340,572 | -19.1% | 0.04% | -27.9% |
| Q2 2017 | $18,141,000 | -5.2% | 420,726 | -7.3% | 0.06% | -7.6% |
| Q1 2017 | $19,132,000 | +24.6% | 453,789 | +13.8% | 0.07% | +20.0% |
| Q4 2016 | $15,353,000 | +13.5% | 398,636 | +27.1% | 0.06% | +10.0% |
| Q3 2016 | $13,528,000 | -26.3% | 313,670 | -26.0% | 0.05% | -28.6% |
| Q2 2016 | $18,367,000 | +6.6% | 423,776 | -0.2% | 0.07% | +2.9% |
| Q1 2016 | $17,223,000 | +11.0% | 424,747 | +10.5% | 0.07% | +9.7% |
| Q4 2015 | $15,514,000 | +11.4% | 384,500 | +6.1% | 0.06% | +6.9% |
| Q3 2015 | $13,932,000 | -7.8% | 362,338 | -0.1% | 0.06% | -1.7% |
| Q2 2015 | $15,107,000 | -4.4% | 362,703 | +6.0% | 0.06% | -3.3% |
| Q1 2015 | $15,795,000 | +28.9% | 342,240 | +19.4% | 0.06% | +29.8% |
| Q4 2014 | $12,251,000 | -2.3% | 286,639 | +5.1% | 0.05% | -7.8% |
| Q3 2014 | $12,542,000 | -8.4% | 272,824 | +6.6% | 0.05% | -7.3% |
| Q2 2014 | $13,690,000 | +4.4% | 255,974 | +4.3% | 0.06% | +1.9% |
| Q1 2014 | $13,114,000 | -9.6% | 245,445 | -9.6% | 0.05% | -8.5% |
| Q4 2013 | $14,503,000 | +5.5% | 271,645 | -0.9% | 0.06% | -3.3% |
| Q3 2013 | $13,752,000 | -24.8% | 274,105 | -25.1% | 0.06% | -26.5% |
| Q2 2013 | $18,287,000 | – | 365,967 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |